Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2024-2032
The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.
Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.
At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.
Infection Surveillance Solutions Market Trends/Drivers:
Rising healthcare-associated infections (HAIs)
The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.
Stringent regulatory compliance for preventing spread of infection
In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.
Advancements in healthcare IT
The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.
Infection Surveillance Solutions Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, deployment type, and end user.
Breakup by Component:
Software
Services
Software represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the component. This includes software and services. According to the report, software represented the largest segment. The software is responsible for the collection, integration, analysis, and presentation of data related to healthcare-associated infections (HAIs) and infectious diseases. It plays a vital role in transforming raw patient data into actionable insights for healthcare providers. It comprises numerous functionalities, such as data integration, real-time monitoring, data analysis, reporting and visualization, and compliance and regulatory support. In line with this, the software enables healthcare organizations to proactively manage infections, improve patient safety, and enhance overall healthcare quality, which is contributing to the growth of the market.
Breakup by Deployment Type:
On-premises
Cloud-based
On-premises accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the deployment type. This includes on-premises and cloud-based. According to the report, on-premises represented the largest segment. On-premises refers to the installation and operation of infection surveillance solutions within the physical infrastructure of a healthcare facility or organization. In this deployment model, all software, hardware, and data storage are maintained locally on-site. On-premises solutions can be customized to meet the specific needs and workflows of the organization and allow for tailored infection surveillance processes. Apart from this, it offers low-latency access to information that allows for real-time monitoring and response to infection trends. Organizations often choose this deployment model when they prioritize data control, security, and compliance while accepting the responsibility of managing their IT infrastructure.
Breakup by End User:
Hospitals
Clinics
Ambulatory Service Centers
Specialty Centers
Others
Hospitals hold the biggest market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory service centers, specialty centers, and others. According to the report, hospitals represented the largest segment. Hospitals are characterized by their high patient volumes, complex care environments, and the critical need for infection control. Moreover, hospitals prioritize patient safety, and infection surveillance is fundamental in achieving this goal. These solutions enable hospitals to monitor, detect, and prevent healthcare-associated infections (HAIs) promptly, thereby reducing patient morbidity and mortality. In addition, efficient infection control helps hospitals optimize resource allocation. By identifying infection trends and risk factors, hospitals can allocate resources effectively and ensure that critical care units and staff are available where needed most.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.
Competitive Landscape:
Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Baxter International Inc.
Becton Dickinson and Company
Centrak Inc. (Halma plc)
Cerner Corporation
CKM Healthcare Incorporated
Ecolab Inc.
International Business Machines Corporation
Medexter Healthcare
Perahealth Inc.
PointClickCare
Premier Inc.
Sunquest Information Systems Inc. (Roper Technologies Inc.)
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent Developments:
In January 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, collaborated with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.
In 2021, Ecolab, the global leader in water, hygiene and infection prevention solutions and services, launched its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe.
In June 2022, Premier, Inc. announced that it is extending its technological capabilities to long-term care (LTC) facilities and providing the same level of clinical surveillance used in the acute setting.
Key Questions Answered in This Report
1. What was the size of the global infection surveillance solutions market in 2023?
2. What is the expected growth rate of the global infection surveillance solutions market during 2024-2032?
3. What are the key factors driving the global infection surveillance solutions market?
4. What has been the impact of COVID-19 on the global infection surveillance solutions market?
5. What is the breakup of the global infection surveillance solutions market based on the component?
6. What is the breakup of the global infection surveillance solutions market based on the deployment type?
7. What is the breakup of the global infection surveillance solutions market based on the end user?
8. What are the key regions in the global infection surveillance solutions market?
9. Who are the key players/companies in the global infection surveillance solutions market?
Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.
At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.
Infection Surveillance Solutions Market Trends/Drivers:
Rising healthcare-associated infections (HAIs)
The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.
Stringent regulatory compliance for preventing spread of infection
In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.
Advancements in healthcare IT
The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.
Infection Surveillance Solutions Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, deployment type, and end user.
Breakup by Component:
Software
Services
Software represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the component. This includes software and services. According to the report, software represented the largest segment. The software is responsible for the collection, integration, analysis, and presentation of data related to healthcare-associated infections (HAIs) and infectious diseases. It plays a vital role in transforming raw patient data into actionable insights for healthcare providers. It comprises numerous functionalities, such as data integration, real-time monitoring, data analysis, reporting and visualization, and compliance and regulatory support. In line with this, the software enables healthcare organizations to proactively manage infections, improve patient safety, and enhance overall healthcare quality, which is contributing to the growth of the market.
Breakup by Deployment Type:
On-premises
Cloud-based
On-premises accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the deployment type. This includes on-premises and cloud-based. According to the report, on-premises represented the largest segment. On-premises refers to the installation and operation of infection surveillance solutions within the physical infrastructure of a healthcare facility or organization. In this deployment model, all software, hardware, and data storage are maintained locally on-site. On-premises solutions can be customized to meet the specific needs and workflows of the organization and allow for tailored infection surveillance processes. Apart from this, it offers low-latency access to information that allows for real-time monitoring and response to infection trends. Organizations often choose this deployment model when they prioritize data control, security, and compliance while accepting the responsibility of managing their IT infrastructure.
Breakup by End User:
Hospitals
Clinics
Ambulatory Service Centers
Specialty Centers
Others
Hospitals hold the biggest market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory service centers, specialty centers, and others. According to the report, hospitals represented the largest segment. Hospitals are characterized by their high patient volumes, complex care environments, and the critical need for infection control. Moreover, hospitals prioritize patient safety, and infection surveillance is fundamental in achieving this goal. These solutions enable hospitals to monitor, detect, and prevent healthcare-associated infections (HAIs) promptly, thereby reducing patient morbidity and mortality. In addition, efficient infection control helps hospitals optimize resource allocation. By identifying infection trends and risk factors, hospitals can allocate resources effectively and ensure that critical care units and staff are available where needed most.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.
Competitive Landscape:
Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Baxter International Inc.
Becton Dickinson and Company
Centrak Inc. (Halma plc)
Cerner Corporation
CKM Healthcare Incorporated
Ecolab Inc.
International Business Machines Corporation
Medexter Healthcare
Perahealth Inc.
PointClickCare
Premier Inc.
Sunquest Information Systems Inc. (Roper Technologies Inc.)
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent Developments:
In January 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, collaborated with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.
In 2021, Ecolab, the global leader in water, hygiene and infection prevention solutions and services, launched its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe.
In June 2022, Premier, Inc. announced that it is extending its technological capabilities to long-term care (LTC) facilities and providing the same level of clinical surveillance used in the acute setting.
Key Questions Answered in This Report
1. What was the size of the global infection surveillance solutions market in 2023?
2. What is the expected growth rate of the global infection surveillance solutions market during 2024-2032?
3. What are the key factors driving the global infection surveillance solutions market?
4. What has been the impact of COVID-19 on the global infection surveillance solutions market?
5. What is the breakup of the global infection surveillance solutions market based on the component?
6. What is the breakup of the global infection surveillance solutions market based on the deployment type?
7. What is the breakup of the global infection surveillance solutions market based on the end user?
8. What are the key regions in the global infection surveillance solutions market?
9. Who are the key players/companies in the global infection surveillance solutions market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DEPLOYMENT TYPE
7.1 On-premises
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloud-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Service Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Specialty Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Centrak Inc. (Halma plc)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cerner Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 CKM Healthcare Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Ecolab Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 International Business Machines Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medexter Healthcare
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Perahealth Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 PointClickCare
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Premier Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY COMPONENT
6.1 Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY DEPLOYMENT TYPE
7.1 On-premises
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cloud-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Service Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Specialty Centers
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Baxter International Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Centrak Inc. (Halma plc)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cerner Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 CKM Healthcare Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Ecolab Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 International Business Machines Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medexter Healthcare
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Perahealth Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 PointClickCare
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Premier Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 SWOT Analysis
LIST OF TABLES
Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2024-2032
Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
Table 7: Global: Infection Surveillance Solutions Market: Key Players
Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2024-2032
Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
Table 7: Global: Infection Surveillance Solutions Market: Key Players
LIST OF FIGURES
Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2023
Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2023
Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2023
Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2023
Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis
Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2023
Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2023
Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2023
Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2023
Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis
